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Derivation and validation of the ED-SAS
score for very early prediction of mortality
and morbidity with acute pancreatitis: a
retrospective observational study
Joseph Miller1,2*† , Yiyang Wu3,4†, Rawan Safa5, Georgiana Marusca1, Sandeep Bhatti6, Guneet Ahluwalia1,
Jad Dandashi1, Harold Gomez Acevedo1, Naureen Farook1, Ashley Scott1, Vidhya Nair1, Angie Adhami1,
Jeffrey Dueweke1, Sudarshan Hebbar7 and Leeland Ekstrom3

Abstract
Background: Existing scoring systems to predict mortality in acute pancreatitis may not be directly applicable to
the emergency department (ED). The objective of this study was to derive and validate the ED-SAS, a simple
scoring score using variables readily available in the ED to predict mortality in patients with acute pancreatitis.
Methods: This retrospective observational study was performed based on patient data collected from electronic
health records across 2 independent health systems; 1 was used for the derivation cohort and the other for the
validation cohort. Adult patients who were eligible presented to the ED, required hospital admission, and had a
confirmed diagnosis of acute pancreatitis. Patients with chronic or recurrent episodes of pancreatitis were excluded.
The primary outcome was 30-day mortality. Analyses tested and derived candidate variables to establish a
prediction score, which was subsequently applied to the validation cohort to assess odds ratios for the primary and
secondary outcomes.
Results: The derivation cohort included 599 patients, and the validation cohort 2011 patients. Thirty-day mortality
was 4.2 and 3.9%, respectively. From the derivation cohort, 3 variables were established for use in the predictive
scoring score: ≥2 systemic inflammatory response syndrome (SIRS) criteria, age > 60 years, and SpO2 < 96%.
Summing the presence or absence of each variable yielded an ED-SAS score ranging from 0 to 3. In the validation
cohort, the odds of 30-day mortality increased with each subsequent ED-SAS point: 4.4 (95% CI 1.8–10.8) for 1
point, 12.0 (95% CI 4.9–29.4) for 2 points, and 41.7 (95% CI 15.8–110.1) for 3 points (c-statistic = 0.77).
Conclusion: An ED-SAS score that incorporates SpO2, age, and SIRS measurements, all of which are available in the
ED, provides a rapid method for predicting 30-day mortality in acute pancreatitis.
Keywords: Acute pancreatitis, Predictive score, Validation study, Emergency department
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Background
Recently, the incidence of acute pancreatitis has risen
worldwide, with results from a retrospective analysis in
the US showing a 13% increase in hospital admissions
over 10 years [1, 2]. The annual incidence of acute pancreatitis in the US ranged from 13 to 45 per 100,000
people [3]. While most patients who present with acute
pancreatitis in the emergency department (ED) achieve
positive outcomes, significant morbidity and mortality
still exists [4]. On average, up to 25% will progress to severe acute pancreatitis, and pancreatic necrosis will develop in 20 to 30% of patients, both of which are
associated with significant mortality [5, 6].
Multiple tools exist to aid clinicians in predicting morbidity
and mortality risk associated with acute pancreatitis. These
include well-known scoring systems such as Ranson’s criteria, the Acute Physiology and Chronic Health Evaluation
(APACHE)-II score, and the Bedside Index for Severity in
Acute Pancreatitis (BISAP) [7–9]. However, these scoring
systems largely incorporate variables collected over 24 h or
more of hospital admission and it may not be possible to obtain a final score until 48 h post-admission. Very early prognostic scores that apply to the ED triage and management of
patients with acute pancreatitis are lacking.
The primary objective of this study was to establish a
simple prognostic assessment of acute pancreatitis that
clinicians can apply in the ED for early disease identification. In developing this objective, two key factors were
observed that were repeatedly present early in severe
acute pancreatitis. Systemic inflammatory response syndrome (SIRS) was a prominent indicator of disease severity [10–12]. Mild to moderate hypoxia was common
and likely associated with early acute lung injury [13].
Hence, these findings were incorporated with other variables often available in the ED to derive and validate the
ED-SAS, a simple scoring system that provides a prognostic assessment of mortality in patients admitted to
the ED with acute pancreatitis.
Methods
Study design and setting

A retrospective analysis was performed at Vanderbilt
University Medical Center (VUMC) in Nashville, TN,
USA and Henry Ford Health System (HFHS) in Detroit,
MI, USA. VUMC is a level 1 trauma center with approximately 125,000 annual ED visits. HFHS includes 9
EDs, 4 of which are free-standing, and 5 hospitals that
experience approximately 460,000 annual ED encounters. An institutional review board at each site approved
the study protocol with waiver of informed consent.
Selection of participants

Data from VUMC were used for the derivation cohort
(January 2013 to September 2017). Data from HFHS
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were used for the validation cohort (January 2014 to
January 2018). Eligible patients were selected in similar
manner to VUMC’s Synthetic Derivative, a de-identified
mirror-image of the system’s electronic health records,
by Nashville Biosciences, a subsidiary of VUMC established to support translational research, and from HFHS’
electronic health records (EPIC, Verona, WI). Eligible
patients were 18 years of age or older, had a diagnosis of
acute pancreatitis (International Classification of Diseases [ICD], 9th Revision, code 577.0 or ICD, 10th Revision, code K85), and required hospital admission within
24 h of presentation in the ED. Only the first encounter
with a patient over the study assessment period was included to ensure that no patient was represented more
than once in the data set. Acute pancreatitis was confirmed through elevated serum lipase levels. We excluded patients with chronic pancreatitis, hepatic failure,
or with a serum lipase <3x upper limit of the normal reference range. While prognostic assessment of patients
discharged from the ED may be useful, we did not include these patients, given high rates of concomitant
chronic pancreatitis and reduced opportunity to obtain
outcomes data given the retrospective nature of the
study.

Data collection and processing

Data collected for the derivation and validation cohorts
included subject-level information on demographics;
relevant comorbidities based on ICD codes; diagnoses of
respiratory failure, sepsis, acute kidney injury (AKI), and
other relevant sequelae as per ICD codes; mechanical
ventilation determined by procedure codes for invasive
mechanical ventilation; hospital procedure and visit records; mortality; and the first ED-recorded lab values
and vital signs. Mechanical ventilation did not include
non-invasive modes of ventilation.
Data analysis pulled electronic health data using standardized methods within each health system. For the
validation cohort only, additional chart abstraction was
performed to assess the accuracy of electronic data collection for the diagnosis of acute pancreatitis. Physician
chart abstractors were blinded to the study hypothesis.
All abstractors were trained before initiating chart abstraction and were provided with a data collection manual that included variable definitions and details. Within
the validation cohort, physicians abstracted 10% of study
charts to authenticate electronic data capture and to test
agreement with electronic chart abstraction for the diagnosis of acute pancreatitis. We tested agreement by calculating the K coefficient for the diagnosis of acute
pancreatitis. Complete data related to whether patients
were alive or dead at the time of hospital discharge were
available. For time points following hospital discharge,

Miller et al. BMC Emergency Medicine

(2021) 21:16

health system data in the validation cohort included
statewide hospital mortality data.
Outcome measures

The primary outcome was 30-day mortality. Secondary
outcomes included 180-day mortality; intensive care unit
(ICU) admission; length of hospital stay; presence of sepsis, respiratory failure, or AKI; and need for dialysis or
mechanical ventilation. To determine these latter outcomes, we used ICD codes documented during the patient’s index hospitalization for acute pancreatitis.
Primary data analysis

We selected predictor variables known to be associated
with mortality from acute pancreatitis based on existing
disease models that were present early in a patient’s ED
evaluation [8, 10, 14, 15]. These predictor variables include age > 60 years, gender, self-reported race/ethnicity,
the Charlson comorbidity index [16], the presence of ≥2
SIRS criteria (heart rate > 90/min, respiratory rate > 20/
min, temperature > 38.0 °C or < 36.0 °C, and white blood
cells > 12 × 109/L or < 4 × 109/L), the presence of SpO2 <
96%, and hematocrit > 44%. The SpO2 cut-off of < 96%
was used as it includes the descending portion of the
oxygen saturation curve. The selection of variables to include in our study’s scoring system was refined to ensure
that only those that are readily available during routine
ED evaluation were included.
For the derivation cohort, these variables were analyzed for their association with 30-day mortality via univariate analysis. We retained variables for the final
model with p-values < 0.10. A complete case analysis
was also performed. To reduce bias in parameter estimates, given the low event rate, multivariable logistic regression with Firth’s penalized likelihood estimate was
utilized [17]. To determine the most parsimonious predictor model, the Akaike Information Criterion was
assessed. In addition, model calibration using graphical
assessment by loess smoothers [18] and model discrimination with area under the receiver operating characteristic curve (c statistic) were evaluated.
We performed logistic regression for the ED-SAS
score categories with 0 as the reference to assess the
odds of death and all secondary outcomes. We first performed this analysis within the derivation data set and
applied this derived predictor score to the validation
sample to assess its association with primary and secondary outcomes. No model recalibration was performed within the validation data. All analyses were
performed with SAS 9.4 (Cary, NC). Analyses were performed between pairs of physician raters, and kappa coefficients (K) were calculated to determine interrater
reliability.
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Results
The derivation cohort included 599 patients, and the validation cohort included 2011 patients. Interrater reliability was excellent for chart review for the diagnosis of
acute pancreatitis with a K coefficient of 0.94. In general,
mean age, SpO2, and respiratory rate were similar between the two cohorts (Table 1). The 30-day mortality
rate was similar across the two cohorts with 25 (4.2%)
deaths in the derivation cohort and 78 (3.9%) in the validation cohort (Table 2). Respiratory failure rates were
also similar between the two cohorts (4.2% vs 5.4%, respectively), but rates of sepsis were higher in the derivation cohort than in the validation cohort (13.4% vs.
6.6%, respectively; Table 2). In addition, length of hospital stay and ICU admissions were higher in the derivation cohort (Table 2).
While four variables were associated with 30-day mortality via univariate analysis in the derivation cohort,
only the presence of ≥2 SIRS criteria, an ED SpO2 saturation < 96%, and age > 60 years were significant upon
multivariate analysis and subsequently retained in the
final ED-SAS Score (Table 3). Based on this, the final
three variables included in the model were SpO2 < 96%,
age > 60 years, and ≥ 2 SIRS criteria (Table 4). Each variable was equally weighed and contributed 0 or 1 points
to an overall score based on the presence or absence of
these three variables, resulting in an ED-SAS range of 0
to 3 points. The probability of 30-day mortality increased incrementally with higher ED-SAS scores for
both cohorts (Fig. 1). In addition, increases in the odds
ratio (OR) for 30-day mortality, 180-day mortality, AKI,
respiratory failure, sepsis, and ICU admission were directly associated with increased ED-SAS score in the validation cohort (Table 5).
Discussion
The incidence of acute pancreatitis has been increasing
worldwide. While multiple risk stratification tools exist,
they come with limitations [1, 2, 7–9]. The 3 most commonly used risk stratification tools in the ED include the
BISAP score, the APACHE II Scoring System, and Ranson’s criteria [1]. Imaging-based scores also exist, which
grade computed tomography findings of pancreatitis, but
these may not be performed routinely and may underestimate severity in patients who present early in the disease course [14, 19–21]. While these scoring systems are
regularly used to predict mortality, they were not designed specifically for utility in the ED. [1, 7–9]
The ability to identify patients with acute pancreatitis
who are at high-risk for mortality using a stratification
tool focused on variables that are collected early in the
ED could potentially lead to rapid identification of patients with poor prognoses while at the same time, identifying those patients who do not require agreement
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Table 1 Baseline characteristics of patients with acute pancreatitis admitted to the ED

a

Derivation Cohort
N = 599

Validation Cohort
N = 2011

Male

316 (52.8)

977 (48.6)

Female

283 (47.3)

1034 (51.4)

53.4 (17.4)

56.1 (17.8)

Black

81 (13.5)

487 (24.2)

White

501 (83.6)

1359 (67.5)

16 (2.7)

165 (8.2)

Hispanic

548 (6.2)

79 (3.9)

Non-Hispanic

562 (93.8)

1886 (93.8)

Unknown

54 (9.0)

20 (1.0)

Heart Rate, bpm

91.2 (20.1)

87.9 (20.2)

Respiratory Rate, breath/min

18.4 (2.9)

18.5 (5.1)

Gender, n (%)

Mean Age, years (SD)
Race, n (%)

Other
Ethnicity, n (%)

Vitals, mean (SD)

Temperature, °C

36.7 (0.6)

36.6 (0.6)

SpO2, %

97.5 (2.7)

97.4 (2.5)

128 (27.83)

171 (13.96)

Stroke

85 (18.48)

120 (9.8)

Congestive Heart Failure

110 (23.91)

250 (20.41)

Dementia

5 (1.09)

90 (7.35)

Diabetes Mellitus

151 (32.83)

443 (36.16)

Myocardial Infarction

54 (11.74)

185 (15.1)

Chronic Kidney Disease

112 (24.35)

323 (26.37)

COPD

138 (30.00)

463 (37.8)

Charlson comorbidity index, mean (SD)

2.6 (2.3)

3.3 (3.7)

≥2 SIRS criteria, n (%)b

182 (30.4)

512 (25.5)

Comorbidities, n (%)
Cancer

Additional Predictive Variables

SpO2 < 96%, n (%)

96 (16.0)

336 (16.7)

WBC > 12 × 109/L, n (%)

259 (43.2)

740 (36.8)

Hematocrit > 44%, n (%)

108 (18.0)

601 (29.9)

a

Additional parameters were not available in the data set; bPresence of 2 or more of the following: fever > 38.0 °C or hypothermia < 36.0 °C, tachycardia > 90
beats/minute, tachypnea > 20 breaths/minute, leukocytosis > 12*10 [9]/L, or leucopoenia < 4*10 [9]/L.
COPD chronic obstructive pulmonary disease; SIRS systemic inflammatory response syndrome; WBC white blood cells

management and for whom home-based care may be
more appropriate. In this study across two health systems and multiple EDs, we derived and validated the
ED-SAS, a simple prognostic tool that focuses on 3 variables, all of which can be collected in the ED and are
readily available in the early evaluation of a patient with
acute pancreatitis: age, pulse oximetry reading on room
air (SpO2 saturation < 96%), and the presence of SIRS
criteria. The score was named ED-SAS as SpO2, Age,
and SIRS are all variables assessed in the ED. Results

from this analysis suggest increased risk of 30-day mortality with increasing ED-SAS score; ED-SAS scoring
could aid in ED prognostication and influence triaging
decisions.
The inclusion of advanced age, SIRS criteria, and low
pulse oximetry are consistent with the existing body of
literature. Age has been validated in existing inpatient
prediction scores. SIRS is known to impact the clinical
course and outcome in acute pancreatitis [10, 22, 23].
SIRS is also an early predictor of severe acute
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Table 2 Primary and secondary outcomes upon review of electronic health record data
Outcome, n (%)

Derivation Cohort
N = 599

Validation Cohort
N = 2011

30-Day Mortality

25 (4.2)

78 (3.9)

180-Day Mortality

91 (15.19)

243 (12.1)

Sepsis

80 (13.36)

133 (6.61)

Acute Kidney Injury

155 (25.88)

445 (22.13)

Respiratory Failure

25 (4.17)

108 (5.37)

Mechanical Ventilation

7 (1.17)

75 (3.7)

Dialysis

9 (1.50)

58 (2.88)

ICU Admission

83 (13.86)

159 (7.91)

Length of stay, mean days (SD)

6.7 (7.6)

3.6 (4.8)

ICU Intensive care unit

pancreatitis, with studies demonstrating that the severity
of acute pancreatitis is greater among patients with SIRS
on day 1 [24]. While less recognized than SIRS, moderate
to severe arterial hypoxia is common in patients with
acute pancreatitis and is related to the respiratory injury
often associated with the inflammatory response seen with
acute pancreatitis [10, 13]. Among patients that die early
from acute pancreatitis, respiratory injury is often a prominent finding and is present in approximately 60% of all
elderly patients who pass from acute pancreatitis within
the first week [15, 25]. Although prior studies used arterial
blood gas measurements to assess hypoxia, we relied on
pulse oximetry in this study, given the infrequent use of
arterial blood gas in the ED for these patients [13].
This retrospective, observational, chart review study,
which relied on commonly documented predictor variables, comes with some limitations. While standardized methods for data collection were used, there
remains a potential for bias, and there may be important predictors of morbidity and mortality that
were not considered. Further, selection bias may exist,
as patients who were discharged directly from the ED
were excluded from the analysis; this limits the
Table 3 Univariate analysis of acute pancreatitis predictor
variables

analysis to those with more severe cases of acute pancreatitis. We did not perform a direct comparison between the ED-SAS score and other common scoring
systems or ED predictors of mortality such as the
quick Sepsis Related Organ Failure Assessment score,
which may have utility in evaluating acute pancreatitis, as it does in sepsis [26]. In addition, the design
for assessing mortality may underestimate the true
rates, given that subjects were not directly contacted,
as electronic health record data were used to determine 30- and 180-day mortality. While it is possible
that some deaths were not accounted for, the potential of systematic bias related to these missing data is
limited by inclusion of statewide hospital death data
within the validation cohort. Future research in this
area should also account for additional biomarkers
and clinical findings, including lactate dehydrogenase,
aspartate aminotransferase, pleural effusion, and mental status. Due to the retrospective nature of data collection, we were surprised to find significant missing
data for some of these variables. The ED-SAS model
provides a simple assessment of high-risk patients
with acute pancreatitis early in their ED course, but it
was not designed to assess outcomes, the intensity of
inpatient services that patients require to adequately
determine eligibility for ED discharge, or outpatient

Predictor

30-Day Mortality Odds Ratio (95% CI)

Female gender

1.1 (0.5–2.7)

Age > 60 yearsa

7.6 (2.5–23.2)

Table 4 ED-SAS Score. A scoring system that utilizes variables
readily available in the ED

Black Race

0.3 (0.0–2.4)

Parameter

Score

Hematocrit > 44%

0.5 (0.1–2.2)

SpO2 < 96%

1

a

SpO2 < 96%

5.7 (2.3–14.2)

Age > 60 years

1

≥2 SIRS criteriaa,b

4.3 (1.0–18.7)

≥2 SIRS criteriaa

1

Charlson Index

1.2 (1.0–1.5)

Total Score, range

0–3

a

Statistically significant predictors upon implementation of the multivariant
analysis that were retained in final model; bFever > 38.0 °C or hypothermia <
36.0 °C, tachycardia > 90 beats/minute, tachypnea > 20 breaths/minute,
leukocytosis > 12*10 [9]/L, or leucopoenia < 4*10 [9]/L.
SIRS Systemic inflammatory response syndrome

a

Presence of 2 or more of the following: fever > 38.0 °C or hypothermia <
36.0 °C, tachycardia > 90 beats/minute, tachypnea > 20 breaths/minute,
Leukocytosis > 12*10 [9]/L, or leucopoenia < 4*10 [9]/L.
ED-SAS Emergency Department SpO2, Age, and SIRS, SIRS Systemic
inflammatory response syndrome
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Fig. 1 Probability of 30-day mortality based on ED-SAS scores. After application of the ED-SAS score, the probability of 30-day mortality increased
incrementally with higher ED-SAS scores for both cohorts

management. However, as this information would be
of great interest to emergency physicians, additional
studies to assess this would be of value. Finally, we
did not compare the ED-SAS score to clinical gestalt
and are therefore unable to assess whether it provides
added value to the clinical judgement of an experienced physician.
Future studies of the ED-SAS should include analysis of all patients admitted to the ED for acute pancreatitis, regardless of severity and admission to
hospital. In doing so, it may be possible to utilize this
predictive scoring system in a broader range of

patients with acute pancreatitis, thereby mitigating selection bias.

Conclusions
In this retrospective, observational analysis of patients
hospitalized for acute pancreatitis, the ED-SAS was derived and validated as a simple predictive tool that could
be used to estimate the 30-day risk of mortality using
patient characteristics commonly available in the ED.
This tool has the potential to aid clinicians in prognosticating patients with acute pancreatitis.

Table 5 Odds of primary and secondary outcomes in validation cohort based on ED-SAS score
ED-SAS score, OR (95% CI)a

ED-SAS = 1

ED-SAS = 2

ED-SAS = 3

30-day Mortality

4.4 (1.8–10.8)

12.0 (4.9–29.4)

41.7 (15.8–110.1)

180-day Mortality

3.1 (1.8–5.4)

6.1 (3.4–10.9)

14.8 (7.3–30.1)

Acute kidney injury

2.0 (1.6–2.6)

3.3 (2.4–4.5)

5.6 (3.4–9.3)

Respiratory failure

2.9 (1.6–4.9)

5.7 (3.1–10.3)

7.6 (3.3–17.2)

Sepsis

2.9 (1.7–5.0)

7.2 (4.1–12.7)

17.1 (8.5–34.3)

ICU Admission

2.3 (1.5–3.5)

3.1 (1.9–5.0)

4.6 (2.3–9.3)

a

Reference is ED-SAS of 0
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